Print

Artisan Pharma, Inc.'s Lead Product, ART-123, Approved in Japan  
2/22/2008 8:32:25 AM

WALTHAM, Mass.--(BUSINESS WIRE)--Artisan Pharma, Inc. today announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan’s lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation (“DIC”) in Japan.
//-->